A Randomized Doubleblind Placebo Controlled Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Spironolactone (Primary)
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
Most Recent Events
- 01 Nov 2012 Last checked against European Clinical Trials Database.
- 16 Sep 2011 Primary endpoint 'Albumin-excretion-rate' has been met.
- 16 Sep 2011 Status changed from not yet recruiting to completed.